Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05050617 · ClinicalTrials.gov registry record

Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism

A clinical trial of Pulmonary Embolism, sponsored by WellSpan Health.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT05050617 is a study of Pulmonary Embolism that is actively recruiting participants, run by WellSpan Health. The registered enrollment target is 250 participants, below the 3,053-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05050617, a study of Pulmonary Embolism, is actively recruiting participants, sponsored by WellSpan Health.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Point-of-care echocardiography

Study Locations (1)

Pennsylvania

  • Wellspan York Hospital - York

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-09-09
Est. Completion 2025-10

Sponsor

WellSpan Health

21 total trials

What the Registry Record Tells You About NCT05050617

The ClinicalTrials.gov registry entry for NCT05050617 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,053-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (92% lower). The listed sponsor is WellSpan Health, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Point-of-care echocardiography is the first listed.

NCT05050617 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05050617 about?

NCT05050617 is a clinical study titled "Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism". This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures o...

What is the current status of trial NCT05050617?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2021-09-09. Estimated completion is 2025-10.

What conditions does trial NCT05050617 study?

This clinical trial studies the following conditions: Pulmonary Embolism.

What interventions are being tested in trial NCT05050617?

The interventions under investigation include: Point-of-care echocardiography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05050617?

This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05050617 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.